Kenvue (KVUE) Slides Over 16% After Kimberly-Clark Acquisition Announcement

Kenvue (KVUE) closed the trading day down by 16.39% today. This significant movement follows the announcement that Kimberly-Clark plans to acquire Kenvue, leading to a realignment of Kenvue's stock price with the proposed acquisition offer.

The primary driver behind today's stock performance is the definitive agreement for Kimberly-Clark to acquire Kenvue in a $49 billion deal. The acquisition values Kenvue shares at $21.01 per share in a cash-and-stock transaction. While the acquisition price may represent a premium over Kenvue's recent valuations given its struggles, the market's reaction suggests that the agreed-upon price is lower than where Kenvue was trading before the announcement, prompting the stock to adjust downwards towards the offer price.

Key aspects of this development include:

• Kimberly-Clark announced a $49 billion deal to acquire Kenvue.
• The acquisition is a cash-and-stock deal, valuing Kenvue shares at $21.01.
• The merger combines major brands like Kleenex, Huggies, Band-Aid, and Tylenol, aiming to create a global health and wellness leader.
• Kenvue's stock had previously fallen by a third this year, facing pressure and struggling since its 2023 spin-off from Johnson & Johnson, attracting activist hedge funds.
• Kenvue had removed its CEO and initiated a strategic review in July, highlighting its operational challenges prior to the acquisition.

In essence, Kenvue's stock performance today reflects the market adjusting its valuation to the concrete acquisition price offered by Kimberly-Clark, driving the share price down as it converges to the definitive $21.01 offer.